Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:397-398 (25 August), doi:10.1136/bmj.39247.754676.BE
Michail Kaklamanos, senior house officer, Petros Perros, consultant endocrinologist
Michail Kaklamanos, Petros Perros Endocrine Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN
Correspondence to: petros.perros{at}ncl.ac.uk
Milk alkali syndrome is easily missed and should be considered in all patients who present with hypercalcaemia
Milk alkali syndrome is the third commonest cause of hospital admissions for hypercalcaemia,1 2 but the diagnosis is often missed.2 3 4 5 Misdiagnosis can lead to unnecessary and potentially invasive investigations and inappropriate treatment
A 76 year old woman was referred to a gastroenterology outpatient clinic with altered bowel habit. She had a six month history of alternating constipation and diarrhoea, and she admitted to polydipsia, polyuria, and nocturia. She had no nausea, vomiting, abdominal pain, or weight loss. Her regular prescriptions included salbutamol inhaler, a calcium channel blocker, and ibuprofen for chronic obstructive pulmonary disease, hypertension, and osteoarthritis. She had a history of dyspepsia caused by gastric erosions noted on gastroscopy. She denied taking vitamin supplements or other over the counter medications. Clinical examination was unremarkable, but routine investigations showed hypercalcaemia (table).
She was admitted for immediate treatment with intravenous fluids and intravenous infusion of disodium pamidronate 90 mg. On the second day after admission, her serum calcium concentration was normal. The results of additional investigations taken before disodium pamidronate was started became available later (table).
There was no clinical evidence of acidosis, such as Kussmaul's respiration, though we did not test her arterial pH. Results of chest radiography, abdominal computed tomography, bone scan, and mammography were all normal. Her serum calcium concentrations remained normal without further need for disodium pamidronate infusions or intravenous fluids.
|
Milk alkali syndrome is a hypercalcaemic disorder initially described in association with excessive consumption of milk and sodium bicarbonate for the treatment of peptic ulcer disease (the Sippy diet).3 4 6 7 The syndrome became rare after the introduction of H2 blockers and proton pump inhibitors in clinical practice. Recent data, however, suggest a rising incidence of milk alkali syndrome as a cause of severe hypercalcaemia, probably as a result of increasing use of medications containing calcium carbonate (mainly dispensed over the counter) and other calcium rich products.1 3 4 Two series of 100 and 125 patients have shown that milk alkali syndrome is the third most common cause of hospital admissions for hypercalcaemia.1 2 The diagnosis is based on a history of ingestion of calcium rich compounds, concordant biochemical findings, and exclusion of other causes, the commonest being primary hyperparathyroidism (associated with an raised serum parathormone) and hypercalcaemia of malignancy (hence the screening tests for malignancy). Rarer causes of hypercalcaemia include thyrotoxicosis (excluded by normal serum thyroid stimulating hormone), Addison's disease (excluded by a high normal serum cortisol concentration) and sarcoidosis (unlikely in view of the normal results for angiotensin converting enzyme).
Milk alkali syndrome should be considered in all patients who present with hypercalcaemia. Preparations that contain calcium carbonate are widely used for many medical conditions, including simple dyspepsia, renal failure (as phosphate binding agents), and prophylaxis or treatment of osteoporosis. The key element to the development of milk alkali syndrome is an increased calcium intake, which is also responsible for the development of metabolic alkalosis and renal failure. The presence of the two latter features defines the advanced form of milk alkali syndrome and progression to it depends on several factors, including individual differences in intestinal absorption of calcium, old age, decreased gastric pH, and pre-existing renal failure. The daily amount of ingested calcium plays an important role in the pathogenesis of milk alkali syndrome, with quantities ranging from 2-15 g calcium carbonate a day being implicated.3 6 7 8 9
Early diagnosis and treatment of hypercalcaemia is associated with a favourable outcome.3 7 8 Altered mental status caused by hypercalcaemia at the time of presentation may affect the accuracy of the history from the patient and pose an obstacle to timely diagnosis and management. A careful history of drug use should always be taken from patients who present with hypercalcaemia and corroborated by relatives, carers, or the patient's primary care physician. The management of milk alkali syndrome is withdrawal of the offending medications and correction of volume depletion with or without calciuresis. Although bisphosphonates have been used, they should be avoided as the above measures are usually effective, increased bone resorption is not thought to play a important pathogenetic role, and hypocalcaemia can result from bisphosphonate use.5
Given that calcium carbonate has replaced milk products as the main source of calcium leading to the syndrome, we suggest that "calcium alkali syndrome" is a more appropriate name.
Competing interests: None declared.
Provenance and peer review: Not commissioned; externally peer reviewed.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care